Carlsmed, Inc. SEC filings CARL

Carlsmed, Inc. has 97 filings in SEC EDGAR's recent list, going back to Nov 19, 2019. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Carlsmed, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 4, 2026 Nov 3, 2026
144 Notice of proposed sale Nov 3, 2026 —
4 Insider transaction Nov 2, 2026 Oct 30, 2026
144 Notice of proposed sale Oct 30, 2026 —
144 Notice of proposed sale Oct 14, 2026 —
4 Insider transaction Oct 6, 2026 Oct 5, 2026
144 Notice of proposed sale Oct 5, 2026 —
4 Insider transaction Oct 1, 2026 Sep 30, 2026
S-8 Employee stock plan registration Oct 1, 2026 —
3 Initial insider ownership Sep 30, 2026 Sep 24, 2026
4 Insider transaction Sep 30, 2026 Sep 28, 2026
3 Initial insider ownership Sep 30, 2026 Sep 28, 2026
144 Notice of proposed sale Sep 30, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 30, 2026 Sep 24, 2026
4/A Filing Sep 15, 2026 Jul 24, 2025
4 Insider transaction Sep 10, 2026 Sep 8, 2026
3 Initial insider ownership Sep 10, 2026 Sep 8, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 8, 2026 Sep 4, 2026
EFFECT Filing Aug 21, 2026 —
S-3 Shelf registration Aug 14, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Jun 22, 2026 Jun 3, 2026
4 Insider transaction Jun 22, 2026 Jun 3, 2026
4 Insider transaction Jun 22, 2026 Jun 3, 2026
4 Insider transaction Jun 22, 2026 Jun 3, 2026
8-K Current report
Shareholder vote results
Jun 3, 2026 Jun 3, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 3, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
S-8 Employee stock plan registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 13, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Material agreement, New debt
Oct 30, 2025 Oct 29, 2025
10-Q Quarterly report Aug 28, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 28, 2025 Aug 28, 2025
4 Insider transaction Jul 24, 2025 Jul 24, 2025
4 Insider transaction Jul 24, 2025 Jul 24, 2025
4 Insider transaction Jul 24, 2025 Jul 22, 2025
4 Insider transaction Jul 24, 2025 Jul 22, 2025
4 Insider transaction Jul 24, 2025 Jul 22, 2025
4 Insider transaction Jul 24, 2025 Jul 24, 2025
4 Insider transaction Jul 24, 2025 Jul 22, 2025
4 Insider transaction Jul 24, 2025 Jul 22, 2025
4 Insider transaction Jul 24, 2025 Jul 22, 2025
4 Insider transaction Jul 24, 2025 Jul 22, 2025
4 Insider transaction Jul 24, 2025 Jul 22, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 24, 2025 —
8-K Current report
Bylaw or fiscal year change, Other events
Jul 24, 2025 Jul 24, 2025
S-8 Employee stock plan registration Jul 24, 2025 —
424B4 Prospectus Jul 24, 2025 —
EFFECT Filing Jul 22, 2025 —
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
3 Initial insider ownership Jul 22, 2025 Jul 22, 2025
CERT Filing Jul 22, 2025 —
8-A12B Filing Jul 21, 2025 —
CORRESP Letter to the SEC Jul 18, 2025 —
CORRESP Letter to the SEC Jul 18, 2025 —
CORRESP Letter to the SEC Jul 15, 2025 —
S-1/A Amended registration statement Jul 15, 2025 —
CORRESP Letter to the SEC Jul 7, 2025 —
S-1 Registration statement Jun 26, 2025 —
CORRESP Letter to the SEC Jun 26, 2025 —
UPLOAD Letter from the SEC Jun 17, 2025 —
DRSLTR Filing May 30, 2025 —
DRS/A Filing May 30, 2025 —
UPLOAD Letter from the SEC May 21, 2025 —
DRS Filing Apr 24, 2025 —
DRSLTR Filing Apr 23, 2025 —
D/A Filing Feb 7, 2025 —
D Filing Mar 21, 2024 —
D Filing Apr 27, 2022 —
D Filing Dec 17, 2020 —
D/A Filing May 15, 2020 —
D Filing Nov 19, 2019 —

Showing 97 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
CARL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
, Emerging growth company
SEC CIK
1794546

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.